Hepion Pharmaceuticals Inc Cash Return on Invested Capital (CROIC) 2 year CAGR is 212.27% for the year ending December 31, 2023, a 510.17% change year over year. The cash return on invested capital ratio measures the profitability of a company's invested capital based on its operating cash flow. It is calculated by dividing operating cash flow by the difference between total assets and current liabilities. This ratio indicates the company's ability to generate cash flow relative to the capital invested, excluding short-term liabilities. A higher ratio suggests more efficient cash flow generation from the invested capital. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.